SCHEMBL2483129

SCHEMBL2483129

Cc1ccc2nc(NC(=O)c3ccc(OCCF)cc3)sc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.68
MAPT P10636 5/20 0.68
GAA P10253 1/20 0.68
CYP2C19 P33261 1/20 0.68
MAP3K5 Q99683 1/20 0.64
NPC1 O15118 6/20 0.64
RAB9A P51151 6/20 0.64
SMN1; SMN2 Q16637 4/20 0.64
HPGD P15428 4/20 0.64
KDM4E B2RXH2 3/20 0.64
KLK7 P49862 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
LMNA P02545 2/20 0.64
MAPK1 P28482 1/20 0.64
SCD O00767 8/20 0.60
TP53 P04637 1/20 0.58
LRRK2 Q5S007 1/20 0.57
HTT P42858 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2482989 0.86 SCD (0.72) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL2483241 0.84 SCD (0.84) ALDH1A1MAP3K5NPC1RAB9ASMN1; SMN2
SCHEMBL12422014 0.84 MAPT (0.66) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL13329390 0.84 MAP3K5 (0.83) ALDH1A1MAPTGAAMAP3K5NPC1
SCHEMBL12199362 0.82 MAP3K5 (0.76) ALDH1A1MAPTMAP3K5NPC1RAB9A
SCHEMBL12199335 0.82 MAP3K5 (0.76) ALDH1A1MAPTMAP3K5NPC1RAB9A
SCHEMBL4917536 0.81 SMN1; SMN2 (0.81) ALDH1A1MAPTCYP2C19NPC1RAB9A
SCHEMBL3348202 0.81 LMNA (0.62) ALDH1A1MAPTCYP2C19NPC1RAB9A
SCHEMBL2483622 0.81 MAP3K5 (0.77) ALDH1A1MAPTGAAMAP3K5NPC1
SCHEMBL4913650 0.80 SCD (0.88) ALDH1A1MAPTGAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376463-A1 BENZOTHIAZOLE AMIDES FOR DETECTION OF AMYLOID BETA Bayer Pharma Aktiengesellschaft (DE) 2011-10-19 EP disclosed
US-20110243846-A1 BENZOTHIAZOLE AMIDES FOR DETECTION OF AMYLOID BETA BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-10-06 US disclosed
WO-2010066357-A1 BENZOTHIAZOLE AMIDES FOR DETECTION OF AMYLOID BETA BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243846-A1 BENZOTHIAZOLE AMIDES FOR DETECTION OF AMYLOID BETA APP, APBA1, BACE1 ALDH1A1 2731/4885MAPT 5/4885GAA 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.